TCL Archive In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed April 6, 1984
TCL Archive Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel April 12, 1974
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
TCL Archive In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony August 26, 1977
TCL Archive Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research March 1, 1974
